Royal Sun Agaricus (Agaricus blazei)

Agaricus blazei is a medicinal mushroom containing beta-glucans and proteoglycans that modulate immune function and glucose metabolism. Clinical studies demonstrate its ability to enhance natural killer cell activity and improve insulin sensitivity in diabetic patients.

Origin & History

Royal Sun Agaricus (Agaricus blazei Murill) is a basidiomycete mushroom native to the highland regions of Brazil, originally described from Florida, USA, and now widely cultivated in Japan and Brazil as a medicinal cultivar variant. It is sourced from the fruiting body or mycelium and typically processed into extracts, powders, or supplements via hot water extraction or drying methods to concentrate bioactive polysaccharides, particularly beta-glucans.

Historical & Cultural Context

ABM has been used in Brazilian folk medicine for immune support and general health, gaining popularity in Japan since the 1990s as a cancer adjunct after cultivation from Brazilian strains. Unlike many medicinal mushrooms, it lacks ancient traditional system documentation and represents primarily modern ethnomedical use spanning approximately 30 years.

Health Benefits

• Supports immune function by preserving T/B cells and enhancing NK cell activity (moderate evidence from RCT in 66 NSCLC patients, PMID: 41595590)
• Improves insulin resistance in type 2 diabetes patients, reducing HOMA-IR (moderate evidence from RCT in 72 patients, PMID: 17309383)
• May help maintain quality of life in cancer patients during recovery (preliminary evidence from phase I trial in 78 patients, PMID: 21584278)
• Enhances natural killer cell activity in elderly populations (preliminary evidence from clinical trial, PMID: 22010847)
• Shows general safety profile with minimal adverse events at studied doses (phase I safety data from 78 patients over 6 months)

How It Works

Agaricus blazei contains beta-1,3-glucans and beta-1,6-glucans that bind to dectin-1 receptors on immune cells, activating complement pathways and enhancing macrophage and NK cell function. The mushroom's proteoglycans and polysaccharides also modulate glucose metabolism by improving insulin receptor sensitivity and reducing inflammatory cytokines like TNF-alpha. These bioactive compounds work synergistically through toll-like receptor signaling to regulate both innate and adaptive immune responses.

Scientific Research

Clinical evidence includes a phase I safety trial (PMID: 21584278) in 78 cancer patients showing 12% mild adverse events over 6 months, and a randomized controlled trial (PMID: 17309383) in 72 type 2 diabetes patients demonstrating improved insulin resistance with 1500mg/day for 12 weeks. A pilot RCT (PMID: 41595590) in 66 post-surgical NSCLC patients showed better T/B cell preservation with ABM supplementation.

Clinical Summary

A randomized controlled trial in 66 non-small cell lung cancer patients showed Agaricus blazei preserved T and B cell counts while enhancing NK cell activity during chemotherapy. Another RCT involving 72 type 2 diabetes patients demonstrated significant reductions in HOMA-IR (insulin resistance marker) after 12 weeks of supplementation. Most studies used doses ranging from 1.5-3g daily of standardized extract. While preliminary results are promising, larger long-term trials are needed to establish definitive therapeutic protocols.

Nutritional Profile

Royal Sun Agaricus (Agaricus blazei) dried fruiting body contains approximately: Protein 40-45% of dry weight (high relative to most fungi, containing all essential amino acids including lysine and arginine at ~3-5% each of total protein); Carbohydrates 35-40% dry weight, dominated by beta-glucans (primarily β-1,3/1,6-glucans at 1.5-4.0 g/100g dry weight and β-1,4-glucans), with total dietary fiber ~15-20% dry weight; Fat 1-3% dry weight including linoleic acid (omega-6) as predominant fatty acid (~70% of total fatty acids) and ergosterol (provitamin D2 precursor) at 0.3-0.9 mg/g dry weight, converting to vitamin D2 upon UV exposure. Key bioactive polysaccharides include agaritine-associated compounds and ATOM (Agaricus blazei Torii Murill) fraction; immunomodulatory polysaccharide-protein complexes (FIII-2-b) are documented. Mineral content per 100g dry weight: potassium ~2,500-3,500 mg, phosphorus ~800-1,200 mg, magnesium ~100-150 mg, zinc ~5-10 mg, copper ~0.5-1.5 mg, selenium ~0.01-0.05 mg (soil-dependent). B-vitamins present: niacin (B3) ~40-60 mg/100g dry, riboflavin (B2) ~2-4 mg/100g dry, thiamine (B1) ~0.2-0.5 mg/100g dry. Bioavailability notes: beta-glucan bioavailability is enhanced by hot-water extraction or cooking, which breaks cell walls (chitin matrix limits raw bioavailability); ergosterol conversion to D2 requires UV exposure post-harvest; protein digestibility is moderate (~60-70%) due to chitin encapsulation; lipid-soluble compounds including ergosterol show improved absorption when consumed with dietary fat.

Preparation & Dosage

Clinically studied doses range from 1-3 grams of extract daily for general immune support (6 months), 1500mg/day of dry extract for diabetes management (12 weeks), with formulations typically standardized for beta-glucan content. Most studies used hot water extracts in powder or capsule form. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Reishi mushroom, Turkey tail, Vitamin D3, Zinc, Beta-glucan complex

Safety & Interactions

Agaricus blazei is generally well-tolerated with mild gastrointestinal upset reported in some users. Due to its immune-modulating effects, it may interact with immunosuppressive medications and should be avoided by organ transplant recipients. Patients on diabetes medications should monitor blood glucose closely as the mushroom may enhance hypoglycemic effects. Safety during pregnancy and lactation has not been established, so use should be avoided during these periods.